Q. What is the Diabetic Messaging Program?
A. PrescribeWellness has selected specific diabetic medications with low second fill rates or low adherence rates in an effort to increase adherence and usage of certain diabetic medications and supplies.

Q. What diabetic medications are included in this program?
A. Humalog, Basaglar, Humulin, Trulicity, Jardiance, Tradjenta, and Verio (test strips and meter).

Q. When did the program communications begin?
A. Humalog started on Monday, October 15th, 2017.
Trulicity started on November 13th, 2017.
Basaglar started on June 8th, 2018.
Humulin started on July 31st, 2018.
Tradjenta and Jardiance started on August 31st, 2018.
One Touch Verio Test Strips started on November 5th, 2018.

Q: Why were these meds selected and why have we expanded?
A: These medications have low second fill rates, or low adherence rates, and since the data has shown an improvement in second fill rates for Trulicity and Humalog (the first two medications in this program), we have expanded to additional medications. We also aim to improve general patient knowledge of these medications.

Q. What happens if the patient does not have a cell phone?
A. The patient will not receive any text messages.

Q. How would patients opt out?
A. The patient has the option to opt out from any communication as we have the opt out option on any text message that is delivered to the patient. Also, if the patient is on the NCL (no call list) or is listed as living in a Nursing home, the patient will not receive any texts.

Q. I don’t want to participate in this program. How can you stop my patients from receiving these text messages?
A. If you would like these communications turned off, please contact our Client Solutions team at 800-960-8147.